Mobilization with etoposide and granulocyte colony-stimulating factor can replace bone marrow harvesting in patients with malignant lymphoma who previously failed to mobilize sufficient stem cells with cyclophosphamide and G-CSF

J Hematother Stem Cell Res. 2000 Aug;9(4):411-3. doi: 10.1089/152581600419053.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Agents, Phytogenic / standards
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / standards
  • Etoposide / administration & dosage
  • Etoposide / standards
  • Graft Survival
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Granulocyte Colony-Stimulating Factor / standards
  • Hematopoietic Stem Cell Mobilization / methods*
  • Hematopoietic Stem Cell Mobilization / standards
  • Hematopoietic Stem Cell Transplantation / methods
  • Hematopoietic Stem Cell Transplantation / standards
  • Humans
  • Leukapheresis / methods
  • Lymphoma / therapy*
  • Middle Aged

Substances

  • Antineoplastic Agents, Phytogenic
  • Granulocyte Colony-Stimulating Factor
  • Etoposide
  • Cyclophosphamide